Humana Inc.

BOVESPA:H1UM34 Stock Report

Market Cap: R$184.2b

Humana Past Earnings Performance

Past criteria checks 0/6

Humana's earnings have been declining at an average annual rate of -7.5%, while the Healthcare industry saw earnings growing at 21.6% annually. Revenues have been growing at an average rate of 11.5% per year. Humana's return on equity is 7.7%, and it has net margins of 1.2%.

Key information

-7.5%

Earnings growth rate

-5.7%

EPS growth rate

Healthcare Industry Growth11.6%
Revenue growth rate11.5%
Return on equity7.7%
Net Margin1.2%
Next Earnings Update29 Jan 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Humana makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BOVESPA:H1UM34 Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24115,0101,35912,8010
30 Jun 24112,0361,71112,6300
31 Mar 24109,2431,99112,6610
31 Dec 23106,3742,48912,6270
30 Sep 23102,3513,01512,5670
30 Jun 2398,7273,37812,4320
31 Mar 2395,6423,11512,2910
31 Dec 2292,8702,80612,1980
30 Sep 2291,4852,80712,2300
30 Jun 2290,5123,14311,8540
31 Mar 2287,4953,03511,0000
31 Dec 2183,0642,93310,1210
30 Sep 2182,2012,6739,7940
30 Jun 2180,4502,4829,7040
31 Mar 2178,8883,7229,9420
31 Dec 2077,1553,36710,0520
30 Sep 2074,3884,1539,0660
30 Jun 2070,5543,5028,4420
31 Mar 2067,7162,6147,7910
31 Dec 1964,8882,7077,3810
30 Sep 1962,7612,5507,3670
30 Jun 1960,7262,5057,3780
31 Mar 1958,7401,7587,4360
31 Dec 1856,9121,6837,5250
30 Sep 1855,9331,5127,1350
30 Jun 1855,0091,3676,9230
31 Mar 1854,2841,8246,6150
31 Dec 1753,7672,4486,4190
30 Sep 1753,4561,8636,6950
30 Jun 1753,8681,8146,7460
31 Mar 1754,3411,4756,9920
31 Dec 1654,3796147,1730
30 Sep 1654,8621,1167,0280
30 Jun 1654,5319806,9660
31 Mar 1654,2561,1007,0840
31 Dec 1554,2891,2767,2950
30 Sep 1553,2561,3207,5600
30 Jun 1552,1311,2967,7810
31 Mar 1550,6211,2097,7990
31 Dec 1448,5001,1477,6390
30 Sep 1446,3599727,4260
30 Jun 1444,4401,0507,0680
31 Mar 1442,5391,1266,6940
31 Dec 1341,3131,2316,3550

Quality Earnings: H1UM34 has a large one-off loss of $555.0M impacting its last 12 months of financial results to 30th September, 2024.

Growing Profit Margin: H1UM34's current net profit margins (1.2%) are lower than last year (2.9%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: H1UM34's earnings have declined by 7.5% per year over the past 5 years.

Accelerating Growth: H1UM34's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: H1UM34 had negative earnings growth (-54.9%) over the past year, making it difficult to compare to the Healthcare industry average (64.3%).

Return on Equity

High ROE: H1UM34's Return on Equity (7.7%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 03:17
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Humana Inc. is covered by 52 analysts. 20 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David ToungArgus Research Company
Hua HaBaird
Ishan MajumdarBaptista Research